Investors prefer to put their money in businesses that reap profits on a regular basis. In order to gauge the extent of profits, there is no better metric than net profit margin. A higher net margin reflects a company's efficiency in converting sales into actual profits. BrainsWay Ltd. (BWAY) , Qifu Technology, Inc. (QFIN) , Great Lakes Dredge & Dock Corporation (GLDD) and The Gorman-Rupp Company (GRC) boast solid net profit margins. Net Profit Margin = Net profit/Sales * 100. In simple terms, net profit is ...

Most of us have heard the dictum "the trend is your friend." And this is undeniably the key to success when it comes to short-term investing or trading. But it isn't easy to ensure the sustainability of a trend and profit from it. Often, the direction of a stock's price movement reverses quickly after taking a position in it, making investors incur a short-term capital loss. So, it's important to ensure that there are enough factors -- such as sound fundamentals, positive earnings estimate revisions, etc. - ...

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving that way. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades. Even though momentum is a popular stock cha ...

BURLINGTON, Mass. and JERUSALEM, Aug. 29, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced the appointment of Richard A. Bermudes, M.D. as Chief Medical Officer (CMO), effective September 1, 2024. Dr. Aron Tendler, M.D., who has served as CMO since 2015, will continue to serve as a collaborator on important strategic research projects. "We are excited ...

On Friday, in his speech at the Fed's Jackson Hole Economic Policy Symposium, Chairman Jerome Powell signaled the first reduction in the benchmark interest rate since March 2020. The Fed fund rate is currently in the range of 5.25-5.5%, its highest level in 23 years. Although Powell refrained from announcing the time and the extent of the rate cut, Wall Street expects the first cut in the September FOMC meeting. A rate cut is likely to benefit small-cap stocks the most, aside from largecaps. At this stage, ...

Shares of Brainsway Ltd. Sponsored ADR (BWAY) have gained 0.9% over the past four weeks to close the last trading session at $8.02, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $12.90 indicates a potential upside of 60.9%. The average comprises four short-term price targets ranging from a low of $11 to a high of $16, with a standard deviation of $2.17. While the lowest estima ...

The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Brainsway Ltd. Sponsored ADR (BWAY) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question. Brainsway Ltd. Sponsored ADR is one of 1018 companies in the Medical ...

Have you been paying attention to shares of Brainsway Ltd. Sponsored ADR (BWAY) ? Shares have been on the move with the stock up 21.1% over the past month. The stock hit a new 52-week high of $8.28 in the previous session. Brainsway Ltd. Sponsored ADR has gained 21.5% since the start of the year compared to the 9.5% move for the Zacks Medical sector and the 8.4% return for the Zacks Medical - Products industry. What's Driving the Outperformance? The stock has an impressive record of positive earnings surpri ...

When it comes to short-term investing or trading, they say "the trend is your friend." And there's no denying that this is the most profitable strategy. But making sure of the sustainability of a trend to profit from it is easier said than done. The trend often reverses before exiting the trade, leading to a short-term capital loss for investors. So, for a profitable trade, one should confirm factors such as sound fundamentals, positive earnings estimate revisions, etc. that could keep the momentum in the s ...

PM Images/DigitalVision via Getty Images BrainsWay (NASDAQ:BWAY) (OTCPK:BRSYF) reported strong earnings again in the second quarter, particularly from a margin perspective. This strength is particularly notable given Neuronetics (STIM) recent struggles. BrainsWay's revenue was up 28% YoY, and while growth is moderating, this is coming against increasingly difficult comparable periods. I previously suggested that BrainsWay's stock should continue to rerate higher as the company's profitable growth trajectory ...